Integrated One-stop Drug Discovery Platform Accelerating Project with High Efficiency
Cardiovascular disease (CVD) is the leading cause of death in the developed as well as in the developing world. CVD continues to be the leading cause of death in the US, and 880,574 people died from CVD in 2016. CVD cause one third of all deaths in China, and 4,344,334 people died from CVD in 2016.
Our experienced team across computation chemistry, medicinal chemistry, bioscience, DMPK, pharmacologist and toxicologist deliver an integrated and flexible discovery. We can provide service as following in cardiovascular disease (CVD):
Target proposal
Target validation
DEL screening
Structure based design
Biochemical assays development
Screening and lead identification
In vitro and in vivo pharmacodynamics
Pharmacokinetics and pharmacodynamics (PK/PD)
Drug metabolism and pharmacokinetics (DMPK)
Non-GLP toxicology
Toxicokinetics (TK)
AMES
IND application and clinical study
HitGen Inc.
Building C2, NO.8, Huigu 1st East Road
Tianfu International Bio-Town,
Shuangliu District, Chengdu City,
Sichuan Province,P.R. China
Tel : +86-28-8519-7385
HitGen Pharmaceuticals Inc.(US Subsidiary)
Tel : +1-(508)-840-9646
Vernalis (R&D) Limited (UK Subsidiary)
Granta Park,Great Abington
Cambridge,CB21 6GB
United Kingdom
Tel : +44(0)1223-895555
We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for
More information